Weighted Average Monthly Premium for Medicare Part D Stand-alone Prescription Drug Plans November 7, 2024 State Indicator
The Connection Between Social Security Disability Benefits and Health Coverage Through Medicaid and Medicare October 24, 2024 Issue Brief This analysis examines who was eligible for Medicare and/or Medicaid between 2002 and 2022 because they received disability benefits from one of the country’s Social Security disability programs, Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI). Many who receive SSDI and SSI qualify for both Medicare and Medicaid, known as dual-eligible individuals.
The Landscape of Medicare and Medicaid Coverage Arrangements for Dual-Eligible Individuals Across States October 24, 2024 Issue Brief This issue brief merged beneficiary-level Medicare and Medicaid data from 2021 to document sources of coverage for dual-eligible individuals nationwide and by state.
What Are the Primary Medicaid Eligibility Pathways for Dual-Eligible Individuals? October 22, 2024 Issue Brief This brief examines current Medicaid eligibility policies and enrollment patterns using data from KFF’s 2024 50-state survey of states’ eligibility and enrollment policies for seniors and people with disabilities, and 2021 Medicare and Medicaid claims data from the Centers for Medicare and Medicaid Services (CMS).
Key Facts About Medigap Enrollment and Premiums for Medicare Beneficiaries October 18, 2024 Issue Brief This brief presents facts about Medigap, including the characteristics of Medicare beneficiaries with a Medigap policy, variation in Medigap enrollment by state, and Medigap premiums.
Medigap May Be Elusive for Medicare Beneficiaries with Pre-Existing Conditions October 18, 2024 Issue Brief This issue brief analyzes federal and state guaranteed issue rules and how they impact beneficiaries’ access to Medigap, including the implications for Medicare beneficiaries with pre-existing conditions and those under age 65 with long-term disabilities. This brief also explores a recently finalized rule: Nondiscrimination in Health Programs and Activities regarding Section 1557 of the Affordable Care Act that may have implications for the Medigap market.